文献速递新发突发、热带与寄生虫病医院感染防控

COVID-19临床研究最小共同结局指标集

A minimal common outcome measure set for COVID-19 clinical research.
PubMed 文献 · Lancet Infect Dis · 2020-06-12

为应对COVID-19疫情,WHO研发蓝图临床特征与管理工作组、国际急性病试验研究者论坛及国际严重急性呼吸与新兴感染联盟共同制定了COVID-19研究的最小共同结局指标集。该指标集包括病毒载量测量(定量PCR或循环阈值)、患者生存测量(出院或60天死亡率)以及使用WHO临床进展量表测量患者在医疗系统中的进展。研究者被敦促在正在进行和未来的研究中纳入这些关键数据元素,以加速数据汇总。

要点

  • 最小共同结局指标集包含病毒载量、生存和临床进展三个要素。
  • 病毒载量用定量PCR或循环阈值测量。
  • 生存用出院或60天死亡率测量,进展用WHO临床进展量表。

核心结论

  • 制定了COVID-19临床研究的最小共同结局指标集,以促进数据汇总。

研究设计与样本

  • 由WHO研发蓝图临床特征与管理工作组、国际急性病试验研究者论坛和国际严重急性呼吸与新兴感染联盟共同制定。

主要发现

  • 指标集包括病毒载量测量(定量PCR或循环阈值)、患者生存测量(出院或60天死亡率)和患者进展测量(WHO临床进展量表)。

关键数值与推荐

  • 病毒载量采用定量PCR或循环阈值测量。
  • 生存采用出院时或60天死亡率测量。
  • 患者进展采用WHO临床进展量表测量,反映患者轨迹和资源使用。

临床怎么用

  • 研究者应在正在进行和未来的COVID-19研究中纳入这些关键数据元素,以加速数据汇总。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are often hastily organised and done using various research tools, with the result that pooling data across studies is challenging. In response to the needs of the rapidly evolving COVID-19 outbreak, the Clinical Characterisation and Management Working Group of the WHO Research and Development Blueprint programme, the International Forum for Acute Care Trialists, and the International Severe Acute Respiratory and Emerging Infections Consortium have developed a minimum set of common outcome measures for studies of COVID-19. This set includes three elements: a measure of viral burden (quantitative PCR or cycle threshold), a measure of patient survival (mortality at hospital discharge or at 60 days), and a measure of patient progression through the health-care system by use of the WHO Clinical Progression Scale, which reflects patient trajectory and resource use over the course of clinical illness. We urge investigators to include these key data elements in ongoing and future studies to expedite the pooling of data during this immediate threat, and to hone a tool for future needs.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020. PMID: 32539990. doi:10.1016/S1473-3099(20)30483-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。